Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Still no PR on Markman results.

You are correct that (per what I read as well) the SEC does not specify court rulings and such as mandatory reportable events.

However, I doubt any reasonable person would regard the milestone event that occurred last Wednesday as "Not Material" to the status and future of this investment.

Also, note that the 7/24/12 PR which announced the MH "victory" in NorCal was followed up by an 8-K - though it was more about ITC actions initiated, with the MH info thrown in.

FWIW,

SGE

Share
New Message
Please login to post a reply